BILL ANALYSIS

HR161

BULLISH

New Source Review Permitting Improvement Act

HR161 (New Source Review Permitting Improvement Act) has been assessed with a bullish outlook for investors. The primary sectors impacted are Energy, Materials and Utilities. View the full bill text on Congress.gov.

bullish

Market Sentiment

6/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

HR161 reported out of House Energy & Commerce Committee on April 28, 2026; now on House Union Calendar awaiting floor vote.

Refiners ($MPC, $PSX) are the primary beneficiaries with 7-day gains of +9.37% and +8.75% respectively, reflecting market pricing of regulatory relief.

The bill redefines NSR 'modification' using a 10-year peak-hourly emission baseline and exempts reliability/safety projects — directly reducing permitting delays and compliance costs.

Chemical companies ($LYB, $DOW) show moderate gains (+4.58%, +2.51% weekly), while specialty chemicals ($DD, $CE) show minimal or negative movement, indicating market differentiation.

No funding authorized; impact is purely deregulatory. Forward passage probability is moderate given partisan committee split (28-23) and no Senate companion bill.

How HR161 Affects the Market

Refining sector stocks are already pricing in regulatory relief, with Marathon Petroleum ($MPC) at $241.81 and Phillips 66 ($PSX) at $173.49 after strong 7-day gains. The divergence from chemical stocks (DuPont down -3.48%, Celanese flat) indicates the market is correctly differentiating: refiners are the pure-play beneficiaries with the highest NSR exposure. Chemical companies have secondary benefit but their 30-day trends remain negative (LYB -9.3%, DOW -4.85%, PSX -6.13%), suggesting macro headwinds (lower product demand, higher feedstock costs) are still weighing on the sector despite the regulatory catalyst. For investors: MPC and PSX have the highest sensitivity to NSR relief given their U.S. refining focus. XOM and CVX offer diversified exposure but have less share price upside from this bill alone. The absence of a Senate companion bill introduces execution risk — if the bill dies in the 119th Congress without passage, some of the recent price gains could retrace. Conversely, if the bill is enacted, MPC and PSX could see further multiple expansion as compliance cost savings are reflected in earnings estimates. The market data from April 28-30 already shows aggressive buying, suggesting institutional positioning for floor passage.

Bill Details

Metric	Value
Bill Number	HR161
Market Sentiment	bullish
Event Date	April 28, 2026
Affected Sectors	Energy, Materials, Utilities
Source	View on Congress.gov →

Summary

HR161 (New Source Review Permitting Improvement Act) reported out of House Energy & Commerce Committee on April 28, 2026. Refiners ($MPC, $PSX) and chemical companies ($LYB, $DOW) show strong 7-day gains of +9.37% and +8.75% respectively, reflecting market pricing of regulatory relief. The bill redefines NSR 'modification' to require a 10-year peak-hourly baseline and exempts reliability/safety projects, directly lowering compliance costs for heavy industry.

Full AI Market Analysis

WHAT HAPPENED: On April 28, 2026, HR161 (New Source Review Permitting Improvement Act) was reported (amended) by the House Committee on Energy and Commerce with report H. Rept. 119-625. The bill was then placed on the Union Calendar (Calendar No. 542), indicating it is ready for floor action. The bill, introduced by Rep. Griffith (R-VA) on January 3, 2025, has 21 cosponsors and passed through subcommittee markup (12-11) on December 10, 2025, and full committee markup (28-23) on January 21, 2026. The legislative trajectory shows partisan momentum but narrow margins. THE MONEY TRAIL: This bill is a regulatory relief mechanism — it does not authorize or appropriate any federal spending. The mechanism is purely deregulatory: amending Clean Air Act Sections 111(a), 169(2), and 171 to redefine 'modification' for NSR permitting. The key change: a physical change at a stationary source is only a 'modification' if the maximum hourly emission rate achievable after the change exceeds the maximum hourly rate achievable in any hour of the prior 10 years. Additionally, changes designed to reduce emissions per unit of production, or to restore/maintain/improve reliability or safety, are explicitly excluded from the modification definition unless the EPA Administrator determines the increase would cause adverse health or environmental effects. STRUCTURAL WINNERS AND LOSERS: The direct beneficiaries are U.S. petroleum refiners and chemical manufacturers with existing stationary sources. Refiners ($MPC, $PSX, $XOM, $CVX) are primary beneficiaries because they operate the most NSR-regulated facilities and have the largest capital stock of aging infrastructure needing reliability upgrades. Chemical companies ($LYB, $DOW) benefit similarly. Celanese ($CE) shows minimal 7-day movement (-0.21%), suggesting the market may consider its specialty chemical operations less impacted. The bill does not affect utilities that operate only in non-attainment areas differently, but coal-fired power plants are indirect beneficiaries. The Presidential Memorandum supporting domestic petroleum production noted in the prompt is a separate executive action and is not analyzed here. REAL MARKET DATA ANALYSIS: The data shows a clear sector rally in heavy industry refining stocks coinciding with the bill's committee report on April 28. Marathon Petroleum ($MPC) surged from $227.21 on April 27 to $241.81 by April 30 (+6.42% in three days, +9.37% for the week). Phillips 66 ($PSX) similarly moved from $164.10 to $173.49 (+5.72% in three days, +8.75% weekly). ExxonMobil ($XOM, +2.75% weekly) and Chevron ($CVX, +2.9% weekly) also gained but less dramatically, consistent with their diversified business models (upstream, midstream, chemicals) diluting the refining-only benefit. Chemical stocks showed mixed reaction: LyondellBasell ($LYB) gained +4.58% weekly and Dow ($DOW) +2.51%, while DuPont ($DD) fell -3.48% and Celanese ($CE) was flat (-0.21%). This divergence supports the causal chain: pure-play commodity refiners benefit most, while specialty chemical exposure is less direct. TIMELINE: The bill is now on the Union Calendar — it awaits scheduling for floor debate and vote in the House. Given it is the 119th Congress (2025-2027), the bill has ~20 months remaining in this Congress. The narrow committee vote (28-23, along party lines) suggests floor passage is not guaranteed without bipartisan modifications. Senate companion legislation has not been introduced — this is a standalone House bill, reducing passage probability. However, the committee report (H. Rept. 119-625) provides legislative history that EPA must consider in future rulemaking, creating some industry certainty even without final passage.